Trend
DailyUptrend (confirmed)
4 hourBearish
1 hourLeaning Bullish
15 minDescending Triangle
5 minLeaning Bearish
Daily trend turns down below $36.12
Key levels
Resistance$38.63
Resistance$37.66
Support$36.70
Support$35.69
Latest news & SEC filings
ProductUCB reports positive week 24 results for BIMZELX from BE BOLD study
ProductUCB and Biogen Release Fresh Trial Results for Lupus Drug Dapirolizumab Pegol
DealUCB picks Veeva Vault CRM for worldwide customer engagement
All UCB news →United Community Banks is a bank holding and financial holding company headquartered in Greenville, South Carolina. Its main subsidiary, United Community Bank, offers checking and savings accounts, various lending options including mortgages and business credit, payment processing, equipment financing, wealth management, trust, private banking, investment advisory, and insurance services. It serves businesses, individuals, government entities, schools, utilities, medical providers, and property firms, mainly across six Southeastern states, with some lending offered nationwide.
Based on the company's 10-K filed Feb 17, 2026.
NYSE · Financial
SEPT Low Target
$38.00
SEPT Mid Target
$41.50
SEPT High Target
$42.00
Analyst Consensus
$41.50
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for UCB.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$44.52
41
Moat Score
NARROW
6/9
Piotroski Score
0.2
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| BRADSHAW RICHARD | officer | Sale | 395 | - | Oct 29, 2026 |
| KUMLER ALAN H | officer | Buy | 2,932 | - | Sep 1, 2026 |
| KUMLER ALAN H | officer | Sale | 113 | $4K | May 15, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
11.7%
3yr Revenue CAGR
8.8%
EPS Growth YoY
28.43%
FCF Growth YoY
17.8%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for UCB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:44 | $37.44 | 2,330 | $$87K | BUY |
| 21:00:38 | $37.44 | 1,226 | $$46K | SELL |
| 21:00:38 | $37.44 | 1,450 | $$54K | SELL |
| 21:00:38 | $37.44 | 7,000 | $$262K | SELL |
| 21:00:38 | $37.44 | 1,849 | $$69K | SELL |
5 dark pool trades shown · $$519K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for UNITED COMMUNITY BANKS INC (UCB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →UNITED COMMUNITY BANKS INC (UCB) is at $37.27, down 0.45% (-$0.17) at the Nov 12, 2026 close.
Latest UCB news — Nov 9, 2026: UCB reports positive week 24 results for BIMZELX from BE BOLD study · Nov 9, 2026: UCB and Biogen Release Fresh Trial Results for Lupus Drug Dapirolizumab Pegol
The average analyst price target for UCB is $41.50, ranging from $38 to $42, based on 4 analysts. Latest: Stephens & Co. maintains on Oct 21, 2026.
Analyst ratings for UCB: 1 Buy, 6 Hold, 1 Sell — consensus Hold.
UCB last reported on Oct 20, 2026: EPS $0.77 vs $0.77 expected — a miss of 0.4%.
UCB trades at a P/E of 12.3 vs a Financial average of 12.3.
Yes. UCB's dividend yield is 3.24%.
Support: $36.70, $35.69, $34.69. Resistance: $37.66, $38.63, $39.50.
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
Nov 9, 2026: UCB reports positive week 24 results for BIMZELX from BE BOLD study · Nov 9, 2026: UCB and Biogen Release Fresh Trial Results for Lupus Drug Dapirolizumab Pegol · Nov 4, 2026: UCB picks Veeva Vault CRM for worldwide customer engagement